Strategic Acquisition PPS was recently acquired by Alcami Corporation, signaling a consolidation in the pharma storage and services space. This presents cross-sell opportunities to Alcami’s broader customer base and potential integration of PPS’s GMP warehousing capabilities with Alcami’s existing distribution networks.

GMP Capacity Operating a GMP facility in Reno with temperature-controlled storage and an ISO-8 clean room positions PPS to pursue contract manufacturing support, cold-chain logistics, and clinical kit assembly services for small to mid-sized biopharma and CROs seeking reliable, compliant storage and operations.

Clinical Focus PPS specializes in small to mid-sized clinical trials with rapid response and high service levels, offering a compelling value proposition to biotech startups and Phase I–II trials seeking flexible, compliant warehousing and distribution during critical trial windows.

Limited Footprint Current facility footprint (~3,200 sq ft) and single-location model create a potential upsell path through expanded capacity, additional storage tiers, or regional expansion partnerships to reduce client risk and improve service levels for growing portfolios.

Revenue Range With reported revenue in the 10–25 million range and a niche in small to mid-sized trials, PPS is attractive to mid-market pharma distributors and specialty logistics players looking to bolster cold-chain capabilities and scalable storage for targeted accounts.